(Q37050156)

17 August 2017

1 reference

title

Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker (English)

1 reference

17 August 2017

George L Bakris

1

1 reference

17 August 2017

1 January 2008

1 reference

Journal of Clinical Hypertension

17 August 2017

1 reference

17 August 2017

10

1 reference

17 August 2017

1 Suppl 1

1 reference

17 August 2017

27-32

1 reference

Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex.

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Hypertension management: results of a new national survey for the hypertension education foundation: Harris interactive

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Hypertension treatment and control in five European countries, Canada, and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Risk factor thresholds: their existence under scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Creating a combination antihypertensive regimen: what does the research show?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Protective effects of angiotensin II interruption: evidence for antiinflammatory actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Vascular inflammation and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Nitric oxide, angiotensin II, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08029.X

10.1111/J.1524-6175.2007.08029.X

21 January 2018

Identifiers

DOI

1 reference

release_vs4znwmexng6tc3w534hgifecm

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vs4znwmexng6tc3w534hgifecm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/vs4znwmexng6tc3w534hgifecm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

18174781

1 reference

PubMed ID

18174781